AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31841818 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc augmentation
Number of subjects: 60
Study 31841818 — intervention group
Group type: COMPARATOR
Intervention: Methylphenidate alone (Control)
Number of subjects: 60
Study 31488115 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-week supervised concurrent (aerobic and strength) exercise intervention program (3 sessions/week, 60 min/session)
Number of subjects: 80
Study 31488115 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract)
Number of subjects: 80
Study 27667329 — intervention group
Group type: EXPERIMENTAL
Intervention: Japan Diet nutritional education program for 6 weeks
Number of subjects: 33
Study 25453742 — intervention group
Group type: COMPARATOR
Intervention: Wavelet phase coherence analysis (WPCO) during sit-to-stand posture change
Number of subjects: 16
Study 25453742 — intervention group
Group type: COMPARATOR
Intervention: Wavelet phase coherence analysis (WPCO) during stand-to-sit posture change
Number of subjects: 16
Study 24155938 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoxia
Number of subjects: 10
Study 24155938 — intervention group
Group type: COMPARATOR
Intervention: Acute moderate hypoxia (FIO2 0.138)
Number of subjects: 10
Study 21139319 — intervention group
Group type: EXPERIMENTAL
Intervention: Health support method facilitating goal attainment (intervention group)
Number of subjects: 99
Study 21139319 — intervention group
Group type: COMPARATOR
Intervention: Instruction in exercise and health support using publicly available media (control group)
Number of subjects: 99
Study 18772855 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium diet (20 mEq/day)
Number of subjects: 200
Study 16425130 — intervention group
Group type: EXPERIMENTAL
Intervention: O157-rEPA vaccine (1 or 2 doses)
Number of subjects: 49
Study 12867304 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 J biphasic shocks
Number of subjects: 1129
Study 12867304 — intervention group
Group type: EXPERIMENTAL
Intervention: 115-130 J biphasic shocks
Number of subjects: 1129
Study 12867304 — intervention group
Group type: COMPARATOR
Intervention: Higher energy monophasic shocks
Number of subjects: 1129
Study 14635316 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight reduction treatment
Number of subjects: 126
Study 14635316 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight reduction and electrotherapy modalities
Number of subjects: 126
Study 14635316 — intervention group
Group type: COMPARATOR
Intervention: Electrotherapy modalities to relieve pain
Number of subjects: 126
Study 9129465 — intervention group
Group type: COMPARATOR
Intervention: Fat-free soup (control)
Number of subjects: 67
Study 9129465 — intervention group
Group type: COMPARATOR
Intervention: Fat-free soup with olestra (33.3 g)
Number of subjects: 67
Study 9129465 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat soup (33.3 g fat)
Number of subjects: 67
Study 8230574 — intervention group
Group type: EXPERIMENTAL
Intervention: Isovolemic hemodilution to a hematocrit of 28%
Number of subjects: 39
Study 8230574 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hemodilution)
Number of subjects: 39
Study 8230574 — intervention group
Group type: EXPERIMENTAL
Intervention: Isovolemic hemodilution
Number of subjects: 39
Study 3023276 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg three times daily)
Number of subjects: 11
Study 3023276 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 11
Study 3023276 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 11
Study 31277298 — intervention group
Group type: EXPERIMENTAL
Intervention: Boys living in a school dormitory, participating in sports teams, exercising on a wet floor, rebellious behavior, and having longer PA exposure time
Number of subjects: 1270
Study 31277298 — intervention group
Group type: EXPERIMENTAL
Intervention: Girls who were sports team members, whose parents were divorced or separated, and those with longer PA exposure time
Number of subjects: 1270
Study 31277298 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall injury incidence
Number of subjects: 1270
Study 31277298 — intervention group
Group type: EXPERIMENTAL
Intervention: Injury risk
Number of subjects: 1270
Study 31277298 — intervention group
Group type: EXPERIMENTAL
Intervention: Injury rate
Number of subjects: 1270
Study 29398254 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeve Gastrectomy (SG)
Number of subjects: 75
Study 29398254 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Modification + Liraglutide (ILM+liraglutide)
Number of subjects: 75
Study 29398254 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Lifestyle Modification (ILM)
Number of subjects: 75
Study 27676671 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mL contrast dye
Number of subjects: 70
Study 27676671 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.0 mL contrast dye
Number of subjects: 70
Study 24919095 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit 'N' Fit Chair Yoga
Number of subjects: 0
Study 24919095 — intervention group
Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 0
Study 23111427 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating radial optic flow
Number of subjects: 0
Study 23111427 — intervention group
Group type: COMPARATOR
Intervention: Smooth radial optic flow
Number of subjects: 0
Study 23111427 — intervention group
Group type: EXPERIMENTAL
Intervention: Microgravity exposure
Number of subjects: 0
Study 23111427 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-flight vection sensitivity
Number of subjects: 0
Study 23111427 — intervention group
Group type: COMPARATOR
Intervention: 1-g vection responses
Number of subjects: 0
Study 20193857 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist arthroscopy for treatment and evaluation of scaphoid fracture and associated carpal injuries
Number of subjects: 40
Study 18581957 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete decongestive physiotherapy (CDP) 60 min
Number of subjects: 24
Study 18581957 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete decongestive physiotherapy (CDP) 30 min plus intermittent pneumatic compression (IPC) 30 min
Number of subjects: 24
Study 15820849 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative self-distraction coping
Number of subjects: 122
Study 15820849 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional support
Number of subjects: 122
Study 15820849 — intervention group
Group type: EXPERIMENTAL
Intervention: Religious-based coping
Number of subjects: 122
Study 15820849 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative distress
Number of subjects: 122
Study 15820849 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral disengagement
Number of subjects: 122
Study 11807347 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve and tendon gliding exercises with splint treatment
Number of subjects: 28
Study 11807347 — intervention group
Group type: COMPARATOR
Intervention: Splint treatment only
Number of subjects: 28
Study 10198656 — intervention group
Group type: EXPERIMENTAL
Intervention: $10 cash
Number of subjects: 1078
Study 10198656 — intervention group
Group type: EXPERIMENTAL
Intervention: Grocery store coupons
Number of subjects: 1078
Study 10198656 — intervention group
Group type: EXPERIMENTAL
Intervention: Bus tokens/fast-food coupons
Number of subjects: 1078
Study 10198656 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational education
Number of subjects: 1078
Study 10198656 — intervention group
Group type: COMPARATOR
Intervention: Usual encouragement
Number of subjects: 1078
Study 7572539 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy (IT)
Number of subjects: 31
Study 7572539 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 31
Study 1656818 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid 1 g in 500 ml of 5% glucose (Group B)
Number of subjects: 16
Study 1656818 — intervention group
Group type: COMPARATOR
Intervention: 500 ml of 5% glucose (Group A)
Number of subjects: 16
Study 6399302 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 20
Study 6399302 — intervention group
Group type: COMPARATOR
Intervention: Amikacin
Number of subjects: 20
Study 31226960 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted esophagectomy (RAE)
Number of subjects: 360
Study 31226960 — intervention group
Group type: COMPARATOR
Intervention: Conventional minimally invasive esophagectomy (MIE)
Number of subjects: 360
Study 29702118 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal therapist contact Cognitive Behavior Therapy (MC-CBT)
Number of subjects: 436
Study 29702118 — intervention group
Group type: COMPARATOR
Intervention: Education (EDU)
Number of subjects: 436
Study 29702118 — intervention group
Group type: COMPARATOR
Intervention: Standard Cognitive Behavior Therapy (S-CBT)
Number of subjects: 436
Study 29702118 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 436
Study 26692119 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan (TLV) plus conventional treatment, n=26
Number of subjects: 52
Study 26692119 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (FRM) increased dosage, n=26
Number of subjects: 52
Study 26692119 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan (TLV)
Number of subjects: 52
Study 26692119 — intervention group
Group type: COMPARATOR
Intervention: Furosemide (FRM) increased dosage
Number of subjects: 52
Study 25430726 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass drug administration (MDA) with praziquantel
Number of subjects: 0
Study 25430726 — intervention group
Group type: COMPARATOR
Intervention: Traditional models (Poisson and negative binomial)
Number of subjects: 0
Study 25430726 — intervention group
Group type: EXPERIMENTAL
Intervention: Zero modified models (zero inflated Poisson and zero inflated negative binomial)
Number of subjects: 0
Study 25430726 — intervention group
Group type: EXPERIMENTAL
Intervention: Hurdle models (Poisson logit hurdle and negative binomial logit hurdle)
Number of subjects: 0
Study 23134162 — intervention group
Group type: EXPERIMENTAL
Intervention: Jet ventilation catheter
Number of subjects: 32
Study 23134162 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous catheter
Number of subjects: 32
Study 23134162 — intervention group
Group type: COMPARATOR
Intervention: Emergency tracheotomy
Number of subjects: 32
Study 19808950 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg per day
Number of subjects: 40
Study 19808950 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg per day
Number of subjects: 40
Study 18423560 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus erlotinib
Number of subjects: 13
Study 15722489 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification of IPV victims and referral to community resources
Number of subjects: 0
Study 15722489 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind randomized controlled trial
Number of subjects: 0
Study 12023696 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 10881
Study 12023696 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (diuretic/beta-blocker)
Number of subjects: 10881
Study 10366118 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg/day for 2 years followed by 10 mg/day for 12-30 months
Number of subjects: 2984
Study 10366118 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate treatment
Number of subjects: 2984
Study 7863988 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 151
Study 1784888 — intervention group
Group type: EXPERIMENTAL
Intervention: S-ibuprofen (400 mg T.I.D.)
Number of subjects: 50
Study 1784888 — intervention group
Group type: COMPARATOR
Intervention: Racemic ibuprofen (600 mg T.I.D.)
Number of subjects: 50
Study 7008642 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled salbutamol powder (0.2 mg/dosis)
Number of subjects: 43
Study 7008642 — intervention group
Group type: COMPARATOR
Intervention: Inhaled salbutamol spray (0.1 mg/dosis)
Number of subjects: 43
Study 31513164 — intervention group
Group type: EXPERIMENTAL
Intervention: Interstitial electrostimulation (IES)
Number of subjects: 64
Study 31513164 — intervention group
Group type: COMPARATOR
Intervention: Cutaneous electrostimulation (control)
Number of subjects: 64
Study 27979034 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous LAA occlusion
Number of subjects: 396
Study 27979034 — intervention group
Group type: COMPARATOR
Intervention: Novel oral anticoagulants (NOAC)
Number of subjects: 396
Study 25458910 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin treatment for 14 days
Number of subjects: 40
Study 23203904 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintendo-Wii Bowling, 60 min/twice a week for 6 weeks
Number of subjects: 27
Study 22741442 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 10 mg bid + VitE 100 mg tid
Number of subjects: 106
Study 22741442 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocarnitine oral solution 1 bottle bid + VitE 100 mg tid
Number of subjects: 106
Study 22741442 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen 10 mg bid
Number of subjects: 106
Study 22741442 — intervention group
Group type: COMPARATOR
Intervention: Levocarnitine oral solution 1 bottle bid
Number of subjects: 106
Study 19931288 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 250 mg (paired group)
Number of subjects: 28
Study 19931288 — intervention group
Group type: COMPARATOR
Intervention: Placebo (unpaired group)
Number of subjects: 28
Study 19931288 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 250 mg (Experiment 2)
Number of subjects: 28
Study 19931288 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Experiment 2)
Number of subjects: 28
Study 17922944 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh yoghurt
Number of subjects: 33
Study 17922944 — intervention group
Group type: COMPARATOR
Intervention: Pasteurised yoghurt
Number of subjects: 33
Study 17922944 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactose intolerance status
Number of subjects: 33
Study 15797063 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorin Slimline valve prosthesis
Number of subjects: 80
Study 15797063 — intervention group
Group type: COMPARATOR
Intervention: St. Jude High Performance valve prosthesis
Number of subjects: 80
Study 15797063 — intervention group
Group type: EXPERIMENTAL
Intervention: Both valves
Number of subjects: 80
Study 12536346 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal vitamin K2 supplementation (15 mg/d Menatetrenone since the 14th day after parturition)
Number of subjects: 77
Study 12536346 — intervention group
Group type: COMPARATOR
Intervention: Control group (without maternal supplementation)
Number of subjects: 77
Study 12536346 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal vitamin K2 supplementation
Number of subjects: 77
Study 9824933 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide 0.1 cc (100 mcg) three times daily subcutaneously for the first seven days post-operatively
Number of subjects: 34
Study 9824933 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Octreotide)
Number of subjects: 34
Study 7988247 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative combined chemotherapy with cyclophosphamide, doxorubicin, and cisplatin (CAP)
Number of subjects: 141
Study 7988247 — intervention group
Group type: COMPARATOR
Intervention: Bacillus Calmette‐Guerin (BCG) and levamisole immunotherapy
Number of subjects: 141
Study 3185461 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (400 mg per os)
Number of subjects: 10
Study 3185461 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29400626 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (n=5)
Number of subjects: 16
Study 29400626 — intervention group
Group type: EXPERIMENTAL
Intervention: Folinic acid (5 mg daily for 4 weeks, n=6)
Number of subjects: 16
Study 29400626 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=5)
Number of subjects: 16
Study 27275104 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen (500 mg)
Number of subjects: 324
Study 27275104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 324
Study 26276750 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy supplementation (50 mg isoflavones per day; n = 46)
Number of subjects: 95
Study 26276750 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 49)
Number of subjects: 95
Study 23751235 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo spray with suggestion to increase BP
Number of subjects: 92
Study 23751235 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo spray with suggestion to decrease BP
Number of subjects: 92
Study 23751235 — intervention group
Group type: COMPARATOR
Intervention: Placebo spray with no suggestion (controls)
Number of subjects: 92
Study 20647234 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Web site (interactive with detailed, personalized timeline)
Number of subjects: 64
Study 20647234 — intervention group
Group type: COMPARATOR
Intervention: Standard Web site
Number of subjects: 64
Study 20647234 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Web site
Number of subjects: 64
Study 18981703 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin film with 2% IM and 10% EC
Number of subjects: 0
Study 18981703 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin film with no EC
Number of subjects: 0
Study 18981703 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin film with 10% EC
Number of subjects: 0
Study 18981703 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin film with carboxyvinyl polymer
Number of subjects: 0
Study 15932725 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (AzA) treatment after conversion from mycophenolate mofetil (MMF), n = 42
Number of subjects: 87
Study 15932725 — intervention group
Group type: COMPARATOR
Intervention: Continued mycophenolate mofetil (MMF) treatment, n = 45
Number of subjects: 87
Study 12667396 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripancreatic arterial ligation and arterial infusion regional chemotherapy (Group B)
Number of subjects: 29
Study 12667396 — intervention group
Group type: COMPARATOR
Intervention: Systemic chemotherapy after surgery (Group A)
Number of subjects: 29
Study 12667396 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study 10373082 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxalic acid total etch technique
Number of subjects: 52
Study 10373082 — intervention group
Group type: COMPARATOR
Intervention: Phosphoric acid enamel etch
Number of subjects: 52
Study 8779014 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymethylmethacrylate
Number of subjects: 81
Study 8779014 — intervention group
Group type: COMPARATOR
Intervention: Discectomy only
Number of subjects: 81
Study 1839435 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (5 mg/day, adjustable to 10 mg/day after 4 weeks)
Number of subjects: 320
Study 1839435 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 320
Study 6133287 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopenthixol decanoate (100 mg 4-weekly to 400 mg 2-weekly)
Number of subjects: 45
Study 6133287 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine decanoate (12.5 mg 4-weekly to 37.5 mg 3-weekly)
Number of subjects: 45
Study 31052212 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural wine
Number of subjects: 55
Study 31052212 — intervention group
Group type: COMPARATOR
Intervention: Conventional wine
Number of subjects: 55
Study 29895500 — intervention group
Group type: EXPERIMENTAL
Intervention: 600L Euvichol® (Test)
Number of subjects: 442
Study 29895500 — intervention group
Group type: COMPARATOR
Intervention: 100L Euvichol® (Comparator)
Number of subjects: 442
Study 26153513 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole (5 years)
Number of subjects: 330
Study 24479893 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led individualised education programme to promote self-care of sleep-activity, including physical training, relaxation exercise, and a CD-based relaxation programme.
Number of subjects: 47
Study 24479893 — intervention group
Group type: COMPARATOR
Intervention: Control group received a brochure about sleep and stress.
Number of subjects: 47
Study 24479893 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led individualised education programme.
Number of subjects: 47
Study 24479893 — intervention group
Group type: COMPARATOR
Intervention: Control group.
Number of subjects: 47
Study 23138830 — intervention group
Group type: EXPERIMENTAL
Intervention: Wand computer-controlled local anaesthesia
Number of subjects: 30
Study 23138830 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 30
Study 20117262 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaxfectin-adjuvanted monovalent plasmid DNA vaccine
Number of subjects: 103
Study 20117262 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaxfectin-adjuvanted trivalent plasmid DNA vaccine
Number of subjects: 103
Study 20117262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 17585668 — intervention group
Group type: EXPERIMENTAL
Intervention: Needling method for harmonizing spleen-stomach, treated twice each day for 10 days
Number of subjects: 72
Study 17585668 — intervention group
Group type: COMPARATOR
Intervention: Motilium 10 mg, oral administration 3 times each day, 30 min before meals
Number of subjects: 72
Study 14691696 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendectomy
Number of subjects: 52
Study 14691696 — intervention group
Group type: COMPARATOR
Intervention: Open appendectomy
Number of subjects: 52
Study 12364420 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum estradiol
Number of subjects: 180
Study 12364420 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum OPG
Number of subjects: 180
Study 12364420 — intervention group
Group type: COMPARATOR
Intervention: Urine markers of bone resorption
Number of subjects: 180
Study 9660911 — intervention group
Group type: EXPERIMENTAL
Intervention: Toronto Stentless Porcine Valve (SPV)
Number of subjects: 112
Study 9660911 — intervention group
Group type: COMPARATOR
Intervention: Carpentier‐Edwards SAV stented bioprosthesis
Number of subjects: 112
Study 7808491 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin therapy
Number of subjects: 0